FDA Brief

Warning letters Drugs

FDA warning letter to

Ketamine Store / www.ketaminestore.org

High riskIssued Jun 23Posted Jul 7Center for Drug Evaluation and Research (CDER)

FDA warned website Ketamine Store for selling unapproved, misbranded ketamine liquid and compounded products online without prescriptions.

What happened

FDA reviewed the website www.ketaminestore.org on February 26, 2026, rather than doing an inspection. The review found ketamine products offered for sale to U.S. consumers, including "KETAMINE LIQUID," "Ketamine Troches" and "KETAMINE NASAL SPRAY," marketed with claims about treating depression, anxiety and pain. FDA says none of these have an approved application, the compounded versions were sold without prescriptions for individual patients, and the labeling lacks adequate directions for use.

What FDA found

  1. The company sells ketamine liquid as a drug without an FDA-approved application for it.

    FD&C Act sections 505(a) and 301(d) (21 U.S.C. 355(a), 331(d))
  2. It sells compounded ketamine troches and nasal spray without prescriptions for identified patients and is not a registered outsourcing facility, so it does not qualify for the compounding exemptions.

    FD&C Act sections 503A and 503B (21 U.S.C. 353a, 353b)
  3. The product labeling does not carry adequate directions for use, so the drugs are misbranded.

    FD&C Act section 502(f)(1) (21 U.S.C. 352(f)(1)); 21 CFR 201.5, 201.115(a)
  4. The company offers prescription drugs for sale without requiring a prescription, which misbrands them while held for sale.

    FD&C Act sections 503(b)(1) and 301(k) (21 U.S.C. 353(b)(1), 331(k))

What FDA wants

FDA tells the company to stop offering any unapproved and misbranded drugs to U.S. consumers, and to send a written response within 15 business days describing the corrections, how it will prevent repeat violations, and supporting documents.

Who should pay attention

  • online pharmacies and websites selling compounded ketamine
  • ketamine and telehealth clinics that refer patients to online sellers
  • compounding pharmacies that supply products sold without patient prescriptions

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. New Green Nutrition Inc.

    FDA says New Green Nutrition sold unapproved drugs online, and its Qu Feng Huo Luo Dan contained hidden dexamethasone.

    High risk
  2. Ong Tien USA LLC

    FDA warned Ong Tien USA LLC that its herbal joint products are unapproved drugs and one contained hidden piroxicam and dexamethasone.

    High risk
  3. Bella’s Nutri Shop Inc.

    Bella’s Nutri Shop sells “Tawon Liar” as an unapproved drug with hidden dexamethasone, tapentadol, and meloxicam.

    High risk
  4. Phuoc Loc Tho Herbals, Inc.

    FDA warned Phuoc Loc Tho Herbals that its herbal products are unapproved new drugs marketed with disease claims.

    High risk